Tsfg LLC Has $754,000 Stock Position in CVS Health Co. (NYSE:CVS)

Tsfg LLC lessened its position in shares of CVS Health Co. (NYSE:CVSFree Report) by 6.3% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 16,800 shares of the pharmacy operator’s stock after selling 1,137 shares during the quarter. Tsfg LLC’s holdings in CVS Health were worth $754,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in CVS. American Century Companies Inc. grew its holdings in CVS Health by 3.0% during the 2nd quarter. American Century Companies Inc. now owns 968,121 shares of the pharmacy operator’s stock worth $57,177,000 after acquiring an additional 28,250 shares during the period. Thoroughbred Financial Services LLC increased its holdings in CVS Health by 31.8% in the second quarter. Thoroughbred Financial Services LLC now owns 4,007 shares of the pharmacy operator’s stock worth $236,000 after purchasing an additional 967 shares in the last quarter. Fairfield Financial Advisors LTD acquired a new position in CVS Health in the second quarter valued at approximately $40,000. Oldfield Partners LLP boosted its holdings in shares of CVS Health by 37.8% during the 2nd quarter. Oldfield Partners LLP now owns 6,200 shares of the pharmacy operator’s stock worth $366,000 after buying an additional 1,700 shares in the last quarter. Finally, Waycross Partners LLC increased its stake in shares of CVS Health by 11.3% in the 2nd quarter. Waycross Partners LLC now owns 207,539 shares of the pharmacy operator’s stock valued at $12,257,000 after acquiring an additional 21,135 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

CVS Health Trading Up 7.4 %

NYSE:CVS opened at $51.54 on Tuesday. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The company has a 50-day moving average price of $51.76 and a 200-day moving average price of $56.49. The stock has a market cap of $64.86 billion, a price-to-earnings ratio of 13.08, a P/E/G ratio of 0.85 and a beta of 0.59.

CVS Health (NYSE:CVSGet Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. During the same period in the previous year, the firm posted $2.21 EPS. The business’s revenue was up 6.3% on a year-over-year basis. Equities analysts predict that CVS Health Co. will post 5.32 EPS for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 5.16%. The ex-dividend date of this dividend is Thursday, January 23rd. CVS Health’s payout ratio is 67.51%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on CVS shares. Evercore ISI upped their price objective on shares of CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a report on Tuesday, October 8th. Cantor Fitzgerald reissued a “neutral” rating and issued a $62.00 price target on shares of CVS Health in a research report on Tuesday, October 1st. StockNews.com downgraded shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Royal Bank of Canada decreased their target price on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research report on Friday, November 15th. Finally, Mizuho dropped their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $68.71.

View Our Latest Report on CVS

CVS Health Company Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

See Also

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.